SMTL ID : 6ddj.1

Crystal Structure of the human BRD2 BD2 bromodimain in complex with a Tetrahydroquinoline analogue

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.05 Å

Oligo State

monomer

Ligands

1 x G7V: 4-{[(2S,4R)-1-acetyl-2-methyl-6-(1H-pyrazol-3-yl)-1,2,3,4-tetrahydroquinolin-4-yl]amino}benzonitrile(Non-covalent)

G7V.1: 14 residues within 4Å: Chain A: W.30, P.31, F.32, V.36, L.41, L.43, Y.46, C.85, Y.88, N.89, H.93, D.94, V.95, M.98 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:W.30, A:F.32, A:V.36, A:L.43, A:V.95, A:V.95 Hydrogen bonds: A:N.89 pi-Stacking: A:W.30 pi-Cation interactions: A:H.93

5 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 3 residues within 4Å: Chain A: K.62, D.67, E.73 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.62, A:E.73 Water bridges: A:E.73 EDO.3: 4 residues within 4Å: Chain A: Q.103, D.104, E.107, F.108 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:D.104 Water bridges: A:D.104, A:D.104 EDO.4: 5 residues within 4Å: Chain A: P.7, L.10, K.11, N.14, M.63 1 PLIP interactions: 1 interactions with chain A Water bridges: A:K.11 EDO.5: 7 residues within 4Å: Chain A: I.49, I.50, K.51, H.52, L.80, N.84, K.87 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:I.49, A:K.51, A:H.52, A:H.52, A:N.84, A:K.87 EDO.6: 2 residues within 4Å: Chain A: L.21, Y.33 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:L.21

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Slavish, P.J. et al., Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer. Cancer Res. (2020)

Release Date

2019-11-13

Peptides

Bromodomain-containing protein 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bromodomain-containing protein 2

Related Entries With Identical Sequence